BioCurex, Inc.(fka BOCX)

[Gold Seeker]

The following is from a press release where Moro is stating they have developed a new format, the Chemiluminescence assay. The abstract for a presentation at the 2006 ISOBM was submitted.

RICHMOND, British Columbia, April 27, 2006

"There is good reason to believe that we can detect other types of early cancer with our new format."

"Our focus on improving the technology has enhanced our opportunities for maximizing our negotiating position in licensing discussions. The new test format will be directly compatible with many of the larger biopharma companies’ proprietary systems and that can expedite their evaluation since their workload to implement the test in their instruments would be minimal. Simply stated, ‘the less work they have to do to adopt the technology, the more likely they are to license’."

http://www.biocurex.com/curexhtml/news/news81.htm

Lets examine how long it took Moro to get the Chemiluminescence assay on Abbott's analyzer. Moro had the procedure developed by the end of April 2006 so lets say that on May 1st, 2006, he began adapting it to Abbott analyzer. Abbott presented the results at the ISOBM in Sept 2007. The abstracts close out two months prior to the meeting so they would have everything done by the first of August. That would be a total of 15 months to adapt the new format to the architect system and PRESENT results.

NOTE: "their workload to implement the test in their instruments would be minimal"

The bocx has made a big deal about how Abbott did not present RECAF until 2 1/2 years after licensing so you should not worry about how long Inverness is taking. I know the following. Inverness licensed RECAF in early Jan 2007. A contingent from BioSite visited Richmond in February to learn about RECAF. Samples of RECAF were sent to BioSite in March 2007. So, the starting date given some slippage would be April 2007

Now, lets look at Inverness and their progress. Moro has stated above there would be minimal adaptation to another system. BioSite got RECAF samples by early April 2008 so lets fast forward 15 months. BioSite, even being as slow as Abbott, should have RECAF developed, working and ready to present results by the end of June 2009.

It is strange that you have heard nothing from Inverness at all. Nothing is mentioned in any of the Inverness presentations that they have RECAF ready to enter trials. Those progress reports submitted to Moro definitely should include that a RECAF test would be ready. Wait a minute, Wittenberg resigned knowing Inverness was ready to go to trials? I doubt that so you can probably suspect that Inverness does not have RECAF ready for trials. What's wrong? Is Inverness not the aggressive fast moving company as stated by Moro? Was Moro wrong about RECAF being easily adapted to other systems? Or maybe Inverness is not even working on RECAF now that Abbott has effectively returned the product.

It has now been 18 months since the effective date of the license with Inverness. That was my benchmark for progress to be shown and it is not happening.